Core Scientific’s largest shareholder to vote against CoreWeave buyout offer
Two Seas Capital, Core Scientific’s largest shareholder, will vote against CoreWeave’s $9B buyout, calling it undervalued and risky for investors.
Two Seas Capital, Core Scientific’s largest shareholder, will vote against CoreWeave’s $9B buyout, calling it undervalued and risky for investors.
